Literature DB >> 22987366

Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.

Hao Wu1, Huiming Xu, Shu Zhang, Xudong Wang, Huijun Zhu, Huilin Zhang, Jin Zhu, Jianfei Huang.   

Abstract

BACKGROUND: The human trophoblastic cell surface antigen 2 (TROP2) gene is associated with the development of malignancies, but its expression in laryngeal squamous cell carcinoma (SCC) and its relationship with clinical characteristics of the disease remain undetermined.
METHODS: Expression of TROP2 protein was detected by immunohistochemistry with a self-made anti-TROP2 antibody in laryngeal SCC tissue microarrays.
RESULTS: Elevated expression of TROP2 was detected in laryngeal SCC tissues compared with adjacent noncancerous tissues. TROP2 expression in laryngeal SCC was related to tumor differentiation (p = .0001) and lymph node metastasis (p = .0352). Cox regression analyses confirmed that TROP2 expression (p = .015), lymph node metastasis (p = .001), degree of differentiation (p = .002), tumor site (p = .021), and T classification (p = .003) were independent prognostic factors.
CONCLUSIONS: TROP2 can be used as an independent prognostic indicator for laryngeal SCC.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  TROP2; laryngeal neoplasms; prognosis; squamous cell carcinoma; tumor marker

Mesh:

Substances:

Year:  2012        PMID: 22987366     DOI: 10.1002/hed.23138

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  17 in total

1.  Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway.

Authors:  Xi Wang; Min Long; Ke Dong; Fang Lin; Yuanyuan Weng; Yongri Ouyang; Li Liu; Junxia Wei; Xi Chen; Ting He; Hui-Zhong Zhang
Journal:  Cancer Biol Ther       Date:  2013-09-04       Impact factor: 4.742

2.  Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.

Authors:  Shota Omori; Koji Muramatsu; Takuya Kawata; Eriko Miyawaki; Taichi Miyawaki; Nobuaki Mamesaya; Takahisa Kawamura; Haruki Kobayashi; Kazuhisa Nakashima; Kazushige Wakuda; Akira Ono; Hirotsugu Kenmotsu; Tateaki Naito; Haruyasu Murakami; Takashi Sugino; Toshiaki Takahashi
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-17       Impact factor: 4.322

3.  Prognostic value of TROP2 in human nasopharyngeal carcinoma.

Authors:  Guo-Fang Guan; De-Jun Zhang; Lian-Ji Wen; Duo-Jiao Yu; Yan Zhao; Lin Zhu; Ying-Yuan Guo; Ying Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.

Authors:  Ning Xu; Zhihong Zhang; Jin Zhu; Lu Xu; Yuhua Li; Lei Duan; Yuan Mao; Hongxia Li
Journal:  Int J Exp Pathol       Date:  2016-04-29       Impact factor: 1.925

5.  Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type.

Authors:  Renjie Chen; Meiping Lu; Jun Wang; Dawei Zhang; Hong Lin; Huijun Zhu; Weiming Zhang; Lin Xiong; Jun Ma; Yuan Mao; Jin Zhu; Jiaren Xu
Journal:  Virchows Arch       Date:  2013-08-25       Impact factor: 4.064

6.  Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma.

Authors:  Yuan Mao; Da-Wei Zhang; Hong Lin; Lin Xiong; Ying Liu; Qing-Dong Li; Jun Ma; Qing Cao; Ren-Jie Chen; Jin Zhu; Zhen-Qing Feng
Journal:  J Exp Clin Cancer Res       Date:  2012-12-12

7.  Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway.

Authors:  Xu-Dong Wang; Qiang Wang; Xiao-Lin Chen; Jian-Fei Huang; Yong Yin; Peng Da; Hao Wu
Journal:  Mol Med Rep       Date:  2015-03-13       Impact factor: 2.952

8.  Trop2 is overexpressed in gastric cancer and predicts poor prognosis.

Authors:  Wei Zhao; Huijun Zhu; Shu Zhang; Hongmei Yong; Wei Wang; Yan Zhou; Bing Wang; Jinbo Wen; Zhenning Qiu; Guipeng Ding; Zhenqing Feng; Jin Zhu
Journal:  Oncotarget       Date:  2016-02-02

9.  The tumor-inhibitory effectiveness of a novel anti-Trop2 Fab conjugate in pancreatic cancer.

Authors:  Yuan Mao; Xiaoying Wang; Feng Zheng; Changjun Wang; Qi Tang; Xiaojun Tang; Ning Xu; Huiling Zhang; Dawei Zhang; Lin Xiong; Jie Liang; Jin Zhu
Journal:  Oncotarget       Date:  2016-04-26

Review 10.  Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.

Authors:  Ping Zeng; Min-Bin Chen; Li-Na Zhou; Min Tang; Chao-Ying Liu; Pei-Hua Lu
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.